利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

154 条记录 (耗时 0.042 秒)

    Antibodies to human CK&bgr;-10/MCP-4
    1.
    发明授权
    Antibodies to human CK&bgr;-10/MCP-4 失效
    人类CKbeta-10 / MCP-4的抗体

    公开(公告)号：US06673344B1

    公开(公告)日：2004-01-06

    申请号：US09717209

    申请日：2000-11-22

    申请人： Haodong Li ,  Mark Adams ,  Solange Hanschke Lima ,  Ralph Alderson ,  Yuling Li ,  David Parmelee ,  John White ,  Edward Appelbaum

    发明人： Haodong Li ,  Mark Adams ,  Solange Hanschke Lima ,  Ralph Alderson ,  Yuling Li ,  David Parmelee ,  John White ,  Edward Appelbaum

    IPC分类号： A61K39395

    CPC分类号： C07K14/52 ,  C07K14/523 ,  Y10S930/14

    摘要： Human chemokine polypeptides and DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemokine polypeptides and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed.

    摘要翻译： 公开了人趋化因子多肽和编码这种趋化因子多肽的DNA（RNA）和通过重组技术产生此类多肽的方法。 还公开了利用这种趋化因子多肽治疗白血病，肿瘤，慢性感染，自身免疫疾病，纤维化病症，伤口愈合和牛皮癣的方法。 还公开了抗这种趋化因子多肽的拮抗剂及其作为治疗类风湿性关节炎，自身免疫性和慢性炎性和感染性疾病，过敏反应，前列腺素依赖性发烧和骨髓衰竭的治疗剂的用途。

    Human chemokines, CK&bgr;4 and CK&bgr;10/MCP-4
    2.
    发明授权
    Human chemokines, CK&bgr;4 and CK&bgr;10/MCP-4 失效
    人类趋化因子，CKbeta4和CKbeta10 / MCP-4

    公开(公告)号：US06174995B1

    公开(公告)日：2001-01-16

    申请号：US08613822

    申请日：1996-02-23

    申请人： Haodong Li ,  Mark Adams ,  Solange Hanschke Lima ,  Ralph Alderson ,  Yuling Li ,  David Parmelee ,  John White ,  Edward Applebaum

    发明人： Haodong Li ,  Mark Adams ,  Solange Hanschke Lima ,  Ralph Alderson ,  Yuling Li ,  David Parmelee ,  John White ,  Edward Applebaum

    IPC分类号： C07K1452

    CPC分类号： C07K14/52 ,  C07K14/523 ,  Y10S930/14

    摘要： Human chemokine polypeptides and DNA/(RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemokine polypeptides and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed.

    摘要翻译： 公开了人类趋化因子多肽和编码这种趋化因子多肽的DNA /（RNA）和通过重组技术产生此类多肽的方法。 还公开了利用这种趋化因子多肽治疗白血病，肿瘤，慢性感染，自身免疫疾病，纤维化病症，伤口愈合和牛皮癣的方法。 还公开了抗这种趋化因子多肽的拮抗剂及其作为治疗类风湿性关节炎，自身免疫性和慢性炎性和感染性疾病，过敏反应，前列腺素依赖性发烧和骨髓衰竭的治疗剂的用途。

    Connective Tissue Growth Factor-2
    4.
    发明申请
    Connective Tissue Growth Factor-2 审中-公开
    结缔组织生长因子-2

    公开(公告)号：US20070154908A1

    公开(公告)日：2007-07-05

    申请号：US11563870

    申请日：2006-11-28

    申请人： Haodong Li ,  Mark Adams

    发明人： Haodong Li ,  Mark Adams

    IPC分类号： C12Q1/68 ,  C07H21/04 ,  C12P21/06 ,  C07K14/475

    CPC分类号： C07K14/475 ,  A61K38/00 ,  A61K48/00 ,  A61K2039/505 ,  C07K2319/00

    摘要： The present invention relates to a human CTGF-2 polypeptide and DNA (RNA) encoding such polypeptide. Also provided is a procedure for producing such polypeptide by recombinant techniques and antibodies and antagonist/inhibitors against such polypeptide. Also provided are methods of using the polypeptide therapeutically for enhancing the repair of connective and support tissue, promoting the attachment, fixation and stabilization of tissue implants and enhancing wound healing. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.

    摘要翻译： 本发明涉及人CTGF-2多肽和编码这种多肽的DNA（RNA）。 还提供了通过重组技术产生这种多肽的方法和针对这种多肽的抗体和拮抗剂/抑制剂。 还提供了用于治疗性地增强连接和支持组织的修复，促进组织植入物的附着，固定和稳定以及增强伤口愈合的方法。 还公开了用于鉴定编码本发明多肽的核酸序列中突变和用于检测本发明多肽的改变水平的诊断测定。

    Human chemokine beta-9
    7.
    发明申请
    Human chemokine beta-9 失效
    人趋化因子β-9

    公开(公告)号：US20060040313A1

    公开(公告)日：2006-02-23

    申请号：US11260166

    申请日：2005-10-28

    申请人： Haodong Li ,  Mark Adams

    发明人： Haodong Li ,  Mark Adams

    IPC分类号： C12Q1/68 ,  C07H21/04 ,  C12P21/04 ,  C07K14/52

    CPC分类号： C07K16/24 ,  A61K38/00 ,  A61K2039/505 ,  C07K14/523 ,  G01N33/564 ,  G01N33/57426 ,  G01N33/6863 ,  G01N2333/52

    摘要： Human Ckβ-9 polypeptides and DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ckβ-9 polypeptides for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such polypeptides and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed. Diagnostic assays are also disclosed which detect the presence of mutations in the Ckβ-9 coding sequence and over-expression of the Ckβ-9 protein.

    摘要翻译： 公开了人Ckbeta-9多肽和编码这种趋化因子多肽的DNA（RNA）和通过重组技术产生这种多肽的方法。 还公开了利用这种Ckbeta-9多肽治疗白血病，肿瘤，慢性感染，自身免疫疾病，纤维化病症，伤口愈合和牛皮癣的方法。 还公开了抗这些多肽的拮抗剂及其作为治疗类风湿性关节炎，自身免疫性和慢性炎性和感染性疾病，过敏反应，前列腺素不依赖性发烧和骨髓衰竭的治疗剂的用途。 还公开了诊断测定法，其检测Ckbeta-9编码序列中突变的存在和Ckbeta-9蛋白的过表达。

    Document Handler System and Method With Timed Operation
    9.
    发明申请
    Document Handler System and Method With Timed Operation 有权
    文件处理系统和方法与定时操作

    公开(公告)号：US20150083802A1

    公开(公告)日：2015-03-26

    申请号：US14033440

    申请日：2013-09-21

    申请人： Mark Henderson ,  Bryan Allen Wilcutt ,  Mark Adams ,  David Christopher Kubajak ,  Steven Johnson

    发明人： Mark Henderson ,  Bryan Allen Wilcutt ,  Mark Adams ,  David Christopher Kubajak ,  Steven Johnson

    IPC分类号： G06Q20/14

    CPC分类号： G06Q20/145 ,  G07F11/00 ,  G07F19/202

    摘要： A document handler system and method includes timed operation functionality in which the manufacturer of the document handler may input coded information in the document handler to establish a timed operation of the document handler which may be contingent on continued payments for use of the document handler. Alternatively, or in addition, the timed operation may be used to establish an appropriate warranty period during which the manufacturer is obligated to provide repairs, modification and/or support for the document handler.

    摘要翻译： 文档处理器系统和方法包括定时操作功能，其中文档处理程序的制造商可以在文档处理程序中输入编码信息，以建立文档处理程序的定时操作，该操作可能依赖于继续使用文档处理程序。 或者或另外，定时操作可用于建立适当的保修期，在此期间制造商有义务为文件处理程序提供修理，修改和/或支持。